TenX Keane Acquisition (TENK) Short Interest Ratio & Short Volume

Short interest is the volume of TenX Keane Acquisition shares that have been sold short but have not yet been closed out or covered. As of July 31st, investors have sold 1,600 shares of TENK short. 0.04% of TenX Keane Acquisition's shares are currently sold short. Learn More on TenX Keane Acquisition's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.04% of TenX Keane Acquisition's floating shares are currently sold short.

TenX Keane Acquisition saw a decline in short interest in the month of July. As of July 31st, there was short interest totaling 1,600 shares, a decline of 96.6% from the previous total of 46,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

TenX Keane Acquisition currently has issued a total of 6,653,000 shares. Some of TenX Keane Acquisition's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TenX Keane Acquisition currently has a public float of 4,270,000 shares.

0.04% of TenX Keane Acquisition's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to TenX Keane Acquisition: Biomea Fusion, Inc. (24.03%), IGM Biosciences, Inc. (4.33%), Sutro Biopharma, Inc. (9.29%), Vor Biopharma Inc. (4.19%), InterCure Ltd. (0.05%), Immunic, Inc. (8.14%), Alto Neuroscience, Inc. (12.98%), Adaptimmune Therapeutics PLC (1.97%), MediciNova, Inc. (0.35%), Ikena Oncology, Inc. (0.39%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.45 billion), Moderna, Inc. ($2.69 billion), Royal Caribbean Cruises Ltd. ($2.55 billion), Paychex, Inc. ($2.13 billion), Rivian Automotive, Inc. ($1.96 billion), ON Semiconductor Corporation ($1.94 billion), Tractor Supply Company ($1.84 billion), Enphase Energy, Inc. ($1.77 billion), Chesapeake Energy Co. ($1.69 billion), and International Paper Company ($1.54 billion). View all of the most shorted stocks.

Short selling TENK is an investing strategy that aims to generate trading profit from TenX Keane Acquisition as its price is falling. TENK shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for TenX Keane Acquisition occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TENK, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TENK, twice per month. The most recent reporting period available is July, 31 2024.